Idera Pharma (IDRA) Posts Break-Even Q3 EPS, Down 8c from Q308
IDRA Hot Sheet
EPS Growth %: 0.0%Financial Fact:
Loss from operations: -5.49M
Today's EPS Names:
TNP, MENT, More
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reports Q3 EPS of $0.00, compared to $0.08 posted for the same period in 2008. Revenue for the quarter was $6.50 million, which compares to the estimate of $11.50 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Pandora (P) Blows Up Expectations as Listener Hours Rip; Guides FY13 Ahead of Views
- ATA, Inc. (ATAI) Misses Q4 EPS by 1c; Guides FY13 Revs Below
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
